Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KMS MedisurgiBOM:540468 79 EV-to-EBIT is 99.57 as of Jul. 27, 2026, which is 99% above its 10-year median of 50.11. GuruFocus rates BOM:540468 with a GF Score™ of 79/100 and a GF Value™ of ₹111.52. The stock has 8 warning signs investors should review. Among 466 Medical Devices & Instruments companies, KMS Medisurgi ranks worse than 92.7% on this metric.
The historical rank and industry rank for KMS Medisurgi's EV-to-EBIT or its related term are showing as below:
BOM:540468'
s EV-to-EBIT Range Over the Past 10 Years
Min: 21.65 Med: 50.11 Max: 100.12
Current: 99.57
During the past 13 years, the highest EV-to-EBIT of KMS Medisurgi was 100.12. The lowest was 21.65. And the median was 50.11.
BOM:540468's EV-to-EBIT is ranked worse than 92.7% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 18.395
vs BOM:540468: 99.57
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
KMS Medisurgi's Enterprise Value for the quarter that ended in Mar. 2026 was ₹414.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. KMS Medisurgi's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KMS Medisurgi EV-to-EBIT Related Terms
KMS Medisurgi EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for KMS Medisurgi's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:540468 vs ISRG, BDX, MDLN: EV-to-EBIT Comparison
For the Medical Instruments & Supplies subindustry, KMS Medisurgi's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KMS Medisurgi EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KMS Medisurgi's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where KMS Medisurgi's EV-to-EBIT falls into.
KMS Medisurgi's current Enterprise Value is ₹434.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. KMS Medisurgi's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹4.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KMS Medisurgi (BOM:540468) has a EV-to-EBIT of 99.57 as of Jul. 27, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on KMS Medisurgi and its competitors. This is 99% above median its historical median of 50.11. Over the past decade, KMS Medisurgi's EV-to-EBIT has ranged from 21.65 to 100.12. According to the industry distribution chart, KMS Medisurgi ranks #432 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 92.7%.
Is KMS Medisurgi's EV-to-EBIT too high?
KMS Medisurgi's current EV-to-EBIT of 99.57 is 99% above median its 10-year median of 50.11. Over the past 10 years, this metric has ranged from a low of 21.65 to a high of 100.12. The Medical Devices & Instruments industry median EV-to-EBIT is 18.40. KMS Medisurgi's value of 99.57 is 441.3% above this industry median. Based on the distribution chart, KMS Medisurgi ranks #432 out of 466 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, KMS Medisurgi has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does KMS Medisurgi's EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, KMS Medisurgi ranks #432 out of 466 companies for EV-to-EBIT. This places KMS Medisurgi in the lower half of its industry. The industry median EV-to-EBIT is 18.40. KMS Medisurgi's value of 99.57 is 441.3% above this benchmark. Historically, KMS Medisurgi's own EV-to-EBIT has ranged from 21.65 to 100.12 over the past decade. While the company's 10-year median is 50.11 vs. the industry median of 18.40, KMS Medisurgi has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.40, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KMS Medisurgi's current EV-to-EBIT of 99.57 is 441.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on KMS Medisurgi and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KMS Medisurgi's current EV-to-EBIT is 99.57, which is 99% above median its own 10-year median of 50.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KMS Medisurgi stock overvalued right now?
KMS Medisurgi (BOM:540468) has a current EV-to-EBIT of 99.57. The stock's GF Value™ is ₹111.52, compared to a current price of ₹132.80 — trading 19.1% above its estimated fair value. The current EV-to-EBIT is 99.57, which is 99% above median its 10-year median of 50.11 and 441.3% above the Medical Devices & Instruments industry median of 18.40. KMS Medisurgi's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For KMS Medisurgi (BOM:540468), the current EV-to-EBIT is 99.57 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KMS Medisurgi (BOM:540468) Overvalued in 2026?
Based on GuruFocus' analysis, KMS Medisurgi stock appears to be overvalued.
The current stock price of ₹132.80 is trading 19.1% above its estimated GF Value™ of ₹111.52.
Key valuation signals for BOM:540468:
EV-to-EBIT: 99.57 (99% above median its 10-year median of 50.11)
GF Value™: ₹111.52 vs. price of ₹132.80 (19.1% above fair value)
Industry Position: 441.3% above the Medical Devices & Instruments median (#432 of 466)
No single metric tells the full story. See the BOM:540468 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KMS Medisurgi Ltd manufactures surgical tapes and dressings for hospitals, institutions, trade associations, exporters, and importers. The company manufactures and undertakes job work of various substartes like non-woven fabrics, PU films, cotton fabrics, and taffeta silk fabrics with adhesive. The company's international presence includes Vietnam, Dubai, Europe, Australia, Cambodia, India, Africa, Philippines, Russia, Pakistan, Bangladesh, and the USA. The company derives revenue from the sale of goods.
79GF Score
Get the complete analysis for BOM:540468
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540468 has been successfully added to your 
